Christopher Turner B. Tech (Hons.) Ph. D is an academic researcher investigating skin inflammation, chronic disease, wound healing, drug development and drug delivery at Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia. Concurrently, he holds an adjunct position at the Future Industries Institute, University of South Australia. Chris returned to Australia in 2021 after 5 years at the University of British Columbia (UBC), Vancouver, Canada, after completing a Canadian Institutes of Health Research (CIHR) Fellowship. He received his Ph.D in Health Sciences at the University of Adelaide.
Dr. Turner's research interests encompass inflammation, aging and chronic disease, with an emphasis on... Read more
About me
Christopher Turner B. Tech (Hons.) Ph. D is an academic researcher investigating skin inflammation, chronic disease, wound healing, drug development and drug delivery at Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia. Concurrently, he holds an adjunct position at the Future Industries Institute, University of South Australia. Chris returned to Australia in 2021 after 5 years at the University of British Columbia (UBC), Vancouver, Canada, after completing a Canadian Institutes of Health Research (CIHR) Fellowship. He received his Ph.D in Health Sciences at the University of Adelaide.
Dr. Turner's research interests encompass inflammation, aging and chronic disease, with an emphasis on skin. There is a focus on investigating mechanisms of inflammaging (progressive increase in generalized inflammation as we age), tissue repair, fibrosis, itch, angiogenesis and the role of proteases in chronic inflammatory disease. Chris has a track record in the development and pre-clinical testing of novel therapeutic agents. Diseases of research interest include pressure ulcers, diabetes, aging, dermatitis, skin blisters, ischemia-reperfusion injury and burns. Current projects are investigating granzymes, a family of serine proteases involved in inflammatory responses, angiogenesis, fibrosis and tissue organization. Also investigating Flightless I, a cytoskeletal actin-remodeling protein and negative regulator of wound repair.
Chris has received a number of awards and recognitions for his contributions to the research field; including Australasian Wound & Tissue Repair Society Young Investigator of the Year, twice awarded USA Wound Healing Society Young Investigator, Calgary Firefighters Award from the Skin Research Group of Canada, Dr. Robert Cowan Award from the University of British Columbia Plastics, Department of Surgery, and Bob Fraser New Investigator Award from The Matrix Biology Society of Australia and New Zealand. He was a finalist in the health category of The Australian Innovation Challenge. Training awards include a NHMRC Dora Lush Ph.D Scholarship, CIHR Research Fellowship, CIHR Institute of Aging Award, and CIHR IMPACT Strategic Training Program Award.
Awards
Research Grants
About me
Doctor of Philosophy Adelaide University
Bachelor of Biotechnlogy Flinders University
Monash Institute of Pharmaceutical Sciences (MIPS), Monash University, 2021-current
Regenerative Medicine, Future Industries Institute, University of South Australia, 2021-current
International Collaboration on Research Discoveries (ICORD), Pathology & Laboratory Medicine, University of British Columbia, 2016-2021
Regenerative Medicine, Future Industries Institute, University of South Australia, 2014-2016
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
Year | Output |
---|---|
2022 |
Open access
7
6
|
2022 |
Open access
|
2021 |
Open access
30
28
|
2019 |
Open access
32
32
|
2017 |
Open access
38
39
13
|
Year | Output |
---|---|
2024 |
Open access
|
2023 |
Open access
9
|
2023 |
3
4
|
2022 |
Open access
7
6
|
2022 |
Open access
|
2021 |
Open access
58
56
|
2021 |
Open access
14
12
|
2021 |
Open access
30
28
|
2020 |
Open access
32
30
|
2019 |
Open access
23
21
|
2019 |
Open access
104
98
|
2019 |
23
23
|
2019 |
85
78
|
2019 |
Open access
32
32
|
2019 |
Open access
32
30
|
2018 |
Open access
30
30
|
2018 |
Open access
40
41
|
2017 |
Open access
20
21
|
2017 |
Open access
38
39
13
|
2016 |
Open access
18
19
|
2016 |
5
6
|
2016 |
36
34
3
|
2015 |
Open access
28
24
6
|
2015 |
Open access
2
|
2015 |
Open access
22
18
|
2015 |
10
10
|
Recently published article on bedsores and aging (npg Aging and Mechanisms of Disease) reviewed in the Lancet: “Granzyme B mediates impaired healing of pressure injuries in aged mice”. Lancet, News in Brief. The Lancet Healthy Longevity. Volume 2, Issue 4, April 2021, Page e193. https://doi.org/10.1016/S2666-7568(21)00063-5
Pressure ulcer in aging paper also reviewed in Science in the City: “Publications of the Week: Granzyme B Mediates Impaired Healing of Pressure Injuries in Aged Skin”. Science in the City. March 2021. http://app.e.stemcell.com/e/es.aspx?s=1832&e=382737&elqTrackId=ad3c6ca8079d45afaa19fa353d0bcc41&elq=a1434f7e731f4dd29704f50bb982fc47&elqaid=30856&elqat=1
Published manuscript describing the role of granzyme B in atopic dermatitis reviewed in VCHRI Insider: "“Getting Rid of the Itch”. In VCHRI Research Insider, 2020. https://www.vchri.ca/stories/articles/2020/06/08/getting-rid-itch
Dermatitis paper also reviewed in UBC Faculty of Medicine Newslwetter: “Researchers Uncover Novel Approach for Treating Eczema”. In UBC Faculty of Medicine newsletter, 2020. https://www.med.ubc.ca/news/researchers-uncover-novel-approach-for-treating-eczema/
Awards
Best Oral Presentation, Skin Research Group of Canada Annual Conference, 2020 (virtual)
Post-Doctoral Fellowship, Canada Institutes of Health Research, 2017-2020
External engagement & recognition
Organisation | Country |
---|---|
Aarhus University Hospital | DENMARK |
Australian National University | AUSTRALIA |
Baker Heart and Diabetes Institute | AUSTRALIA |
British Columbia Professional Firefighters’ Burn and Wound Healing Group | CANADA |
Flinders University | AUSTRALIA |
Hokkaido University | JAPAN |
Laval University | CANADA |
Leiden University Medical Centre | NETHERLANDS |
McMaster University | CANADA |
Monash University | AUSTRALIA |
Osaka City University | JAPAN |
Research Center Borstel | GERMANY |
SA Pathology | AUSTRALIA |
South Australian Health and Medical and Research Institute (SAHMRI) | AUSTRALIA |
Tampere University Hospital | FINLAND |
University of Adelaide | AUSTRALIA |
University of Alberta | CANADA |
University of British Columbia | CANADA |
University of California | UNITED STATES |
University of Edinburgh | UNITED KINGDOM |
University of Kent | UNITED KINGDOM |
University of Lubeck | GERMANY |
University of Northern British Columbia | CANADA |
University of South Australia | AUSTRALIA |
University of Toronto | CANADA |
University of Turku | FINLAND |
University of Zaragoza | SPAIN |
Vancouver Coastal Health Research Institute | CANADA |
viDA Therapeutics | CANADA |
Western University | CANADA |
External engagement & recognition
“Publications of the Week: Granzyme K Expressed by Classically Activated Macrophages Contributes to Inflammation and Impaired Remodeling”. Science in the City. November 2018. https://scienceinthecity.com/2018/11/19/granzyme-k-expressed-classically-activated-macrophages-contributes-inflammation-impaired-remodeling/
“Featuring Photoacoustic Imaging, Nanosafety and More”. Feature in Advanced Science News, 31st Jan 2017. http://www.advancedsciencenews.com/featuring-photoacoustic-imaging-nanosafety-januarys-advanced-healthcare-materials-covers/
“Online medical workers change the way we see, hear and feel”. Feature in The Australian newspaper by Cheryl Jones, 2015. http://www.theaustralian.com.au/innovationchallenge/online-medical-workers-change-the-way-we-see-hear-and-feel/story-fnj8drfn-1227580153653
“Healing wounds team is Innovation Challenge finalist”. UniSA News November 2015. Publicizes the wound healing team from Future Industries Institute as a finalist in ‘The Australian’ Innovation Challenge 2015. http://w3.unisa.edu.au/unisanews/2015/November/story6.asp#Healing_wounds
Wound Management Innovation CRC newsletter, Edition 29, December 2015. Publicizes the wound healing team from Future Industries Institute as a finalist in ‘The Australian’ Innovation Challenge 2015. http://www.woundcrc.com/communications.html#publications
Australasian Wound & Tissue Repair Society newsletter, Volume 9, Issue 2, December 2015. Publicizes the wound healing team from Future Industries Institute as a finalist in ‘The Australian’ Innovation Challenge 2015. http://us9.campaign-archive1.com/?u=df1f839e984247e066d6635b3&id=5d2aef8f71&e=35e9f82614
“Protecting protein drugs”. Australian Microscopy & Microanalysis Research Facility, Profile 2015. Article discussing the use of microparticles to deliver the therapeutic antibody Infliximab to chronic wounds. Describes the published work of McInnes et al., J. Mater. Chem. B, 3, 4123, 2015
“CRC Researchers at the Australian Innovation Challenge 2015: Review. Wound Management Innovation CRC Newsletter, 2015
“Australian Innovation Challenge 2015: Review”. Australasian Wound & Tissue Repair Society Newsletter, 2015
Teaching & student supervision
Supervisions from 2010 shown
Thesis title | Student status |
---|---|
Antibiotic-alternative therapies for the treatment of wound infection | Current |
Defining the role of Granzyme K in skin inflammation and chronic itch | Current |